DK0741570T3 - Forebyggelse eller reduktion af fotosensibiliserings- og/eller fototoksicitetsreaktioner på antiinfektionsmedikamenter - Google Patents

Forebyggelse eller reduktion af fotosensibiliserings- og/eller fototoksicitetsreaktioner på antiinfektionsmedikamenter

Info

Publication number
DK0741570T3
DK0741570T3 DK95907337T DK95907337T DK0741570T3 DK 0741570 T3 DK0741570 T3 DK 0741570T3 DK 95907337 T DK95907337 T DK 95907337T DK 95907337 T DK95907337 T DK 95907337T DK 0741570 T3 DK0741570 T3 DK 0741570T3
Authority
DK
Denmark
Prior art keywords
photosensitization
prevention
reduction
packaging material
infective drugs
Prior art date
Application number
DK95907337T
Other languages
Danish (da)
English (en)
Inventor
Paul Dale Klimstra
Barbara Roniker
Edward Allen Swabb
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK0741570T3 publication Critical patent/DK0741570T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Photometry And Measurement Of Optical Pulse Characteristics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95907337T 1994-01-28 1995-01-12 Forebyggelse eller reduktion af fotosensibiliserings- og/eller fototoksicitetsreaktioner på antiinfektionsmedikamenter DK0741570T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/188,296 US5668134A (en) 1994-01-28 1994-01-28 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
PCT/US1995/000213 WO1995020387A1 (en) 1994-01-28 1995-01-12 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications

Publications (1)

Publication Number Publication Date
DK0741570T3 true DK0741570T3 (da) 2003-09-01

Family

ID=22692575

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95907337T DK0741570T3 (da) 1994-01-28 1995-01-12 Forebyggelse eller reduktion af fotosensibiliserings- og/eller fototoksicitetsreaktioner på antiinfektionsmedikamenter

Country Status (9)

Country Link
US (2) US5668134A (pt)
EP (2) EP1384479A1 (pt)
AT (1) ATE239478T1 (pt)
AU (1) AU1560595A (pt)
DE (1) DE69530673T2 (pt)
DK (1) DK0741570T3 (pt)
ES (1) ES2199238T3 (pt)
PT (1) PT741570E (pt)
WO (1) WO1995020387A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
US20060141036A1 (en) * 1997-12-12 2006-06-29 Andrx Labs Llc HMG-CoA reductase inhibitor extended release formulation
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20040037895A1 (en) * 2002-08-23 2004-02-26 Alex Zhu Methods of treating involuntary facial spasms and facial wrinkles
US7435237B2 (en) 2003-06-02 2008-10-14 Boston Scientific Scimed, Inc. Mixing syringes with breakable septums
EP1488787A1 (en) * 2003-06-20 2004-12-22 Berlin-Chemie Ag Topical stabilized formulations containing ketoprofen
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
RU2612810C2 (ru) * 2015-02-26 2017-03-13 Игорь Михайлович Корниловский Способ применения нестероидных противовоспалительных средств в эксимерлазерной хирургии роговицы
US20220142208A1 (en) * 2020-11-12 2022-05-12 Bossa Nova Superfruit Company Sparkling water micronutrient delivery system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US429556A (en) * 1890-06-03 Truss
EP0107150B2 (de) * 1982-10-18 1992-04-15 Siemens Aktiengesellschaft Vorrichtung zur Abgabe von Medikamenten
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
GB8719932D0 (en) * 1987-08-24 1987-09-30 Professional Packaging Ltd Medication timing device
US5142484A (en) * 1988-05-12 1992-08-25 Health Tech Services Corporation An interactive patient assistance device for storing and dispensing prescribed medication and physical device
US5170380A (en) * 1990-12-14 1992-12-08 Wheaton Holding, Inc. Medication container holding device indicating usage time
US5313439A (en) * 1992-07-17 1994-05-17 Dan Albeck Timer device for medications
US5331919A (en) * 1992-08-03 1994-07-26 John Root Medication scheduling device

Also Published As

Publication number Publication date
US5668134A (en) 1997-09-16
WO1995020387A1 (en) 1995-08-03
EP1384479A1 (en) 2004-01-28
DE69530673D1 (de) 2003-06-12
EP0741570B1 (en) 2003-05-07
EP0741570A1 (en) 1996-11-13
DE69530673T2 (de) 2004-04-08
ES2199238T3 (es) 2004-02-16
ATE239478T1 (de) 2003-05-15
US6172069B1 (en) 2001-01-09
AU1560595A (en) 1995-08-15
PT741570E (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
ATE152910T1 (de) Verwendung von taxol zur herstellung eines arzneimittels zur behandlung von krebs
DK0741570T3 (da) Forebyggelse eller reduktion af fotosensibiliserings- og/eller fototoksicitetsreaktioner på antiinfektionsmedikamenter
ATE235482T1 (de) Isocumarinderivate und deren verwendung in medikamenten
DE3781730D1 (de) 1-hydroxy-3-(n-methyl-n-propylamino)propan-1,1-diphosphonsaeure verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel.
DE59409311D1 (de) Aminosäurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE59010312D1 (de) 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
FR2703051B1 (fr) Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
ATE212837T1 (de) Pharmazeutische zubereitung zur behandlung akuter rhinitiden, enthaltend sympthomimeticum und pantothenol und/oder pantothensäure
OA09190A (fr) "Procédés de préparation de dérivés d'acides benzocycloalcényl dihydroxy alcanoïques et de médicaments les contenant".
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
OA09238A (fr) Dérivés d'isoindolinone, leurs procédés de préparation et les médicaments les contenant.
DE69426865D1 (de) Pharmazeutische Zusammensetzungen enthaltend Pyryliumverbindungen, Pyryliumsalze und Verfahren zur Herstellung eines Medikaments enthaltend diese Verbindungen
FR2707085B1 (fr) Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE3664631D1 (en) Polyprenyl compounds, processes for preparing them, and pharmaceutical composition containing them
DE59008921D1 (de) Dibenzo(1,5)dioxocin-5-one-Derivate, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung.
ATE133949T1 (de) 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
ATE105570T1 (de) Modifizierte menschliche anti-rh(d)-antikoerper.
MX9200600A (es) Medicamento que contiene lacidipina, para el tratamiento o prevencion de arteriosclerosis.
DE69102310D1 (de) Pyridylsulfonylharnstoff- und Pyridylsulfonylthioharnstoff-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
OA08184A (fr) Agents anti-hypertentifs, compositions pharmaceutiques les contenant et procédé de préparation desdits agents et compositions.